Tag » Hepatitis B

Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA.

MEDICINE August 2017 V.96 N.33

Chen, Ping PhDa,b; Xie, Qinfen MSa; Lu, Xuan BAb; Yu, Chengbo PhDb; Xu, Kaijin PhDb; Ruan, Bing PhDb; Cao, Hongcui PhDb; Gao, Hainv PhDa; Li, Lanjuan MDb,* 210 kata lagi

Metodos Diagnosticos

Prevent Hepatitis Get Tested, Seek Treatment

Observed on July 28, World Hepatitis Day aims to raise global awareness and understanding of viral hepatitis, the diseases that it causes, besides honoring Nobel Laureate Dr. 207 kata lagi

Cure Hepatitis

Prevent Hepatitis Get Tested, Seek Treatment

Observed on July 28, World Hepatitis Day aims to raise global awareness and understanding of viral hepatitis, the diseases that it causes, besides honoring Nobel Laureate Dr. 206 kata lagi

Hepatitis

Babies will now be offered Hepatitis B vaccine with routine jabs

From today all babies born in the UK will be offered the hepatitis B jab as part of their routine immunisations.

Public Health England hopes the move will help battle viral infections that cause cirrhosis and liver cancer. 292 kata lagi

Health

Compulsory Viral Hepatitis Screening is a Pathway to Elimination


By: Marcus J. Hopkins, Blogger

At the International AIDS Society’s (IAS’) 4th Annual HIV/Viral Hepatitis Co-Infection Meeting in Paris, France, aside from all of the various data regarding rates of infection around the globe and various approaches to eradicating Hepatitis B and C (HBV/HCV, respectively) by the World Health Organization’s (WHO’s) target year of 2030, one assertion rang true throughout: … 748 kata lagi

Time to re-evaluate the effect of the adolescent booster of hepatitis B vaccine

International Journal of Infectious Diseases July 2017 V.60 N.7 P.88-90

Editorial –

Ellie Carmody

Division of Infectious Diseases and Immunology, New York University School of Medicine, New York, New York, USA… 147 kata lagi

Epidemiología

FDA approves Vosevi for Hepatitis C

FDA approves Vosevi for Hepatitis C

07/18/2017

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. 529 kata lagi

Breakthrough Therapy Designation